<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">MRP</journal-id><journal-title-group><journal-title>Medical Research and Practice</journal-title></journal-title-group><issn>2993-9690</issn><eissn>2993-9704</eissn><publisher><publisher-name>Art and Technology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.61369/mrp.6130</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>胰十二指肠切除术胰瘘预防及管理策略的新进展</title><url>https://artdesignp.com/journal/MRP/2/4/10.61369/mrp.6130</url><author>周凯丽</author><pub-date pub-type="publication-year"><year>2024</year></pub-date><volume>2</volume><issue>4</issue><history><date date-type="pub"><published-time>2024-04-20</published-time></date></history><abstract>胰腺瘘是胰十二指肠切除术的一种严重并发症，有可能引发局部或全身性的并发症，例如出血或腹腔感染，这些并发症可能会降低患者的生活质量，严重时甚至可能危及生命。本研究综合评述了胰十二指肠切除术后胰腺瘘的管理策略，探讨了如何在尊重患者生命尊严和生活质量的前提下，通过科学、合理的治疗手段，最大限度地减轻患者痛苦，降低并发症风险，为患者提供全面、细致、精准的医疗服务。</abstract><keywords>胰十二指肠切除术,胰瘘,综述,预防策略,管理策略</keywords></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>[1] 张昕宁，董烨，周毅，等．胰十二指肠切除术后胰瘘风险评估系统的研究进展［J］．临床与病理杂志，2022,42(02):506-511.[2] 李扬，史亚波，涂建华，等．胰十二指肠切除术后胰瘘发生的危险因素及预防［J］．中华肝脏外科手术学电子杂志，2023,12(3):352-355.[3] 郑继盛，苏云，宫淑萍，等．胰十二指肠切除术后胰瘘风险预测模型研究进展［J］．护理研究，2022,36(20):3636-3639.[4]BASSI C,MARCHEGIANI G,DERVENIS C,et al.The 2016 update of the International Study Group(ISGPS)definition and grading of postoperative pancreatic fistula:11 Years After［J］．Surgery,2017,161(3):584-591.[5] 滕达，许悦，杨青松，等．胰十二指肠切除术后临床胰瘘的危险因素分析及预测评价［J］．大连医科大学学报，2024,46(2):124-131.[6]FURBETTA N,GIANARDI D,GUADAGNI S,et al.Somatostatin administration following pancreatoduodenectomy:a case-matched comparison according to surgicaltechnique,body mass index,American Society of Anesthesiologists&amp;rsquo;score and Fistula Risk Score［J］．Surg Today,2021,51(6):1044-1053.[7]HU B,WAN T,ZHANG W,et al.Risk factors for postoperative pancreatic fistula:Analysis of 539 successive cases of pancreaticoduodenectomy［J］．World journal of gastro enterology:WJG,2016,22(34):7797-7805.[8] 张博林，徐新建，周崇峰．胰十二指肠切除术后影响胰瘘的危险因素分析［J］．新疆医学，2020,50(09):961-966.[9] 徐煜，张军峰，花荣．奥曲肽预防胰十二指肠切除术后胰瘘的研究进展［J］．外科理论与实践，2022,27(1):83-86.[10] 余俊，任超逸，崔巍，等．胰十二指肠切除术后胰瘘风险预测模型的建立：基于2016 新版胰瘘定义及分级系统［J］．临床肝胆病杂志，2024,40(04):773-781.[11] 徐勇．胰十二指肠切除术后胰瘘的危险因素分析［D］．苏州大学，2024.[12]PILLARISETTY V G,ABBASI A,PARK J O,et al.A phase II trial of lanreotide for the prevention of postoperative pancreatic fistula［J］．HPB,2022,24(11):2029-2034.[13]KLOMPMAKER S,van HILST J,WELLNER U F,et al.Outcomes After Minimally-invasive Versus Open Pancreatoduodenectomy:A Pan-European Propensity Score Matched Study［J］．Annals of surgery,2020,271(2):356-363.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
